59935-49-8

Basic information

• Product Name: BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE
• Synonyms: BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE;Benzyl 2,3,4-tri-O-benzyl-alpha-D-glucopyranoside
• CAS NO: 59935-49-8
• Molecular Formula: C₃₄H₃₆O₆
• Molecular Weight: 540.652
• Mol File: 59935-49-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• Solubility: Chloroform; Dichloromethane
• CAS DataBase Reference: BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE(59935-49-8)
• EPA Substance Registry System: BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE(59935-49-8)

Safety Data

• Hazardous Substances Data: 59935-49-8(Hazardous Substances Data)

Usage

Description

BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE is a chemical compound that serves as a side product in the synthesis of Isomaltose-13C (I821252), a labeled form of Isomaltose. It is involved in the transformation of maltose into prebiotic isomaltooligosaccharides through the action of a novel α-glucosidase enzyme derived from Xantophyllomyces dendrorhous.

Uses

Used in Pharmaceutical Industry:
BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE is used as an intermediate compound in the synthesis of Isomaltose-13C, which is important for research and development purposes in the pharmaceutical industry. Its role in the synthesis process aids in the production of labeled compounds for various applications, such as drug development and metabolic studies.
Used in Research and Development:
BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE is utilized in research and development for the study of novel α-glucosidase enzymes, such as the one from Xantophyllomyces dendrorhous. This enzyme plays a crucial role in the transformation of maltose into prebiotic isomaltooligosaccharides, which have potential health benefits and applications in the food and pharmaceutical industries.
Used in Prebiotic Production:
Although BENZYL 2,3,4-TRI-O-BENZYL-A-D-GLUCOPYRANOSIDE is a side product, it may have potential applications in the production of prebiotics, such as isomaltooligosaccharides. These prebiotics can be used in various industries, including food and pharmaceuticals, to promote gut health and support the growth of beneficial bacteria.

Upstream product

• 2280-44-6 D-Glucose 
• 203632-36-4 benzyl 6-tert-butyldimethylsilyl-D-glucopyranoside 
• 34246-23-6 benzyl D-glucopyranoside 
• 100-51-6 benzyl alcohol 
• 492-61-5 β-D-glucose 
• 1423019-40-2 benzyl 2,3,4-tri-O-benzyl-6-tert-butyldimethylsilyl-D-glucopyranoside 
• 100-39-0 benzyl bromide 
• 186697-04-1 benzyl 4,6-O-benzylidene-α-D-glucopyranoside 
• 953812-26-5 (3R,4S,5R,6R)-2,3,4,5-tetrakis(benzyloxy)-6-((trityloxy)methyl)tetrahydro-2H-pyran 
• 58527-86-9 Benzyl 2,3-di-O-benzyl-α-D-glucopyranoside 
• 100-44-7 benzyl chloride 
• 58527-85-8 benzyl 4,6-O-benzylidene-2,3-tri-O-benzyl-α-D-glucopyranoside 

Downstream Products

• 85339-01-1 Benzyl-2,3,4-tri-O-benzyl-6-O-(3,4,6-tri-O-acetyl-2-azido-2-desoxy-α-D-galactopyranosyl)-α-D-glucopyranosid 
• 83906-38-1 benzyl O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1->6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 112104-67-3 (Benzyl-2,3,4-tri-O-benzyl-α-D-glucopyranosid-6)-(2,2,2-trichlorethyl)-(triethylammonium)-phosphat 
• 96323-23-8 benzyl 6-O-(2-O-acetyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 96323-23-8 benzyl 6-O-(2-O-acetyl-3,4,6-tri-O-benzyl-α-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 96031-33-3 Benzyl-3)-O-(2-azido-4,6-di-O-benzoyl-2-desoxy-α-D-galactopyranosyl)-(1->6)-2,3,4-tri-O-benzyl-α-D-glucopyranosid> 
• 83921-72-6 benzyl O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1<*>4)-O-(2,3,6-tri-O-benzyl-β-D-glucopyranosyl)-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 83921-71-5 benzyl O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1<*>4)-O-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 136337-37-6 Benzyl 6-O-(7-O-allyl-2,3,4,6-tetra-O-benzyl-L-glycero-β-D-manno-heptopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranose 
• 136337-36-5 Benzyl 6-O-(7-O-allyl-2,3,4,6-tetra-O-benzyl-L-glycero-α-D-manno-heptopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyranose 
• 83921-76-0 benzyl O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1<*>6)-O-(2,3,4-tri-O-benzyl-β-D-glucopyranosyl)-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 83921-75-9 benzyl O-(2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl)-(1<*>6)-O-(2,3,4-tri-O-benzyl-α-D-glucopyranosyl)-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 83921-70-4 benzyl O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-(1<*>3)-O-(2,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 83921-69-1 benzyl O-(2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl)-(1<*>3)-O-(2,4,6-tri-O-benzyl-α-D-glucopyranosyl)-(1<*>6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 

Relevant articles and documents

INHIBITORS OF MALARIAL AND PLASMODIUM FALCIPARUM HEXOSE TRANSPORTER AND USES THEREOF

Provided are molecules capable of binding to binding pockets of Plasmodium falciparum hexose transporter (PfHT) or analogs thereof and complexes comprising the same. Also provided herein are inhibitors of PfHT, pharmaceutical compositions comprising the i

Addressing the biochemical foundations of a glucose-based "trojan horse"-strategy to boron neutron capture therapy: From chemical synthesis to in vitro assessment

Boron neutron capture therapy (BNCT) for cancer is on the rise worldwide due to recent developments of in-hospital neutron accelerators which are expected to revolutionize patient treatments. There is an urgent need for improved boron delivery agents, and herein we have focused on studying the biochemical foundations upon which a successful GLUT1-targeting strategy to BNCT could be based. By combining synthesis and molecular modeling with affinity and cytotoxicity studies, we unravel the mechanisms behind the considerable potential of appropriately designed glucoconjugates as boron delivery agents for BNCT. In addition to addressing the biochemical premises of the approach in detail, we report on a hit glucoconjugate which displays good cytocompatibility, aqueous solubility, high transporter affinity, and, crucially, an exceptional boron delivery capacity in the in vitro assessment thereby pointing toward the significant potential embedded in this approach.

Electrochemical assay to detect influenza viruses and measure drug susceptibility

An electrochemical assay has been designed to rapidly diagnose influenza viruses. Exposure of a glucose-bearing substrate to influenza viruses or its enzyme, neuraminidase (NA), releases glucose, which was detected amperometrically. Two methods were used